Kenneth Patrick  Lorton net worth and biography

Kenneth Lorton Biography and Net Worth

COO of Schrodinger

Patrick Lorton, executive vice president and chief technology officer and chief operating officer, software, joined Schrödinger in 2006. He is responsible for defining Schrödinger’s technology platform, as well as directing all software engineering teams. Pat joined the company as an engineer, and has worked on an array of science projects and provided leadership to both Maestro and LiveDesign development. He received his bachelor’s degrees in Computer Science, Chemistry, and Mathematics from Indiana University, during which time he focused his research on High Performance Computing and applied Molecular Dynamics.

What is Kenneth Patrick Lorton's net worth?

The estimated net worth of Kenneth Patrick Lorton is at least $988.79 thousand as of March 5th, 2026. Lorton owns 89,241 shares of Schrodinger stock worth more than $988,790 as of March 29th. This net worth approximation does not reflect any other investments that Lorton may own. Learn More about Kenneth Patrick Lorton's net worth.

How do I contact Kenneth Patrick Lorton?

The corporate mailing address for Lorton and other Schrodinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrodinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on Kenneth Patrick Lorton's contact information.

Has Kenneth Patrick Lorton been buying or selling shares of Schrodinger?

Within the last three months, Kenneth Patrick Lorton has sold $28,464.05 in shares of Schrodinger stock. Most recently, Kenneth Patrick Lorton sold 1,222 shares of the business's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $12.90, for a transaction totalling $15,763.80. Following the completion of the sale, the executive vice president now directly owns 89,241 shares of the company's stock, valued at $1,151,208.90. Learn More on Kenneth Patrick Lorton's trading history.

Who are Schrodinger's active insiders?

Schrodinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Margaret Dugan (Insider), Ramy Farid (CEO), Jenny Herman (SVP), Rachit Jain (CFO), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), Kenneth Lorton (COO), Geoffrey Porges (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrodinger's active insiders.

Are insiders buying or selling shares of Schrodinger?

During the last twelve months, insiders at the sold shares 14 times. They sold a total of 33,458 shares worth more than $649,577.89. The most recent insider tranaction occured on March, 6th when CAO Jenny Herman sold 608 shares worth more than $7,806.72. Insiders at Schrodinger own 21.0% of the company. Learn More about insider trades at Schrodinger.

Information on this page was last updated on 3/6/2026.

Kenneth Patrick Lorton Insider Trading History at Schrodinger

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2026Sell1,222$12.90$15,763.8089,241View SEC Filing Icon  
2/10/2026Sell925$13.73$12,700.2552,651View SEC Filing Icon  
2/12/2024Sell901$28.29$25,489.2936,487View SEC Filing Icon  
8/9/2023Sell10,000$40.06$400,600.0037,388View SEC Filing Icon  
See Full Table

Kenneth Patrick Lorton Buying and Selling Activity at Schrodinger

This chart shows Kenneth Patrick Lorton's buying and selling at Schrodinger by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Schrodinger Company Overview

Schrodinger logo
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Read More

Today's Range

Now: $11.08
Low: $10.95
High: $11.54

50 Day Range

MA: $12.97
Low: $11.08
High: $17.33

2 Week Range

Now: $11.08
Low: $10.94
High: $27.63

Volume

991,801 shs

Average Volume

1,168,326 shs

Market Capitalization

$817.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57